Clinical Trials Browser

Completed × Interventional × Cytokine Release Syndrome × Clear all

NCT04150913 2025-11-25

A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

Phase 2 Completed

15 enrolled 17 charts

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Neurotoxicity Syndromes

NCT04466098 2025-01-29

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Phase 2 Completed

8 enrolled 21 charts

Cytokine Release Syndrome, COVID-19, Lymphoma, Follicular, Respiratory Distress Syndrome

NCT05510596 2024-08-09

MR-ICANS

Phase NA Completed

Cytokine Release Syndrome, Lymphoma, B-Cell, Neurotoxicity Syndromes

NCT04358406 2023-11-28

Rhu-pGSN for Severe Covid-19 Pneumonia

Phase 2 Completed

64 enrolled 17 charts

Cytokine Release Syndrome, COVID-19, Lymphoma, Follicular, Pneumonia

NCT02761915 2021-08-17

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Phase 1 Completed

17 enrolled 17 charts

Cytokine Release Syndrome, Neuroblastoma, Recurrence

NCT02000817 2019-06-24

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

Phase 1/2 Completed

30 enrolled 21 charts

Cytokine Release Syndrome, Diabetes Mellitus, Diabetes Mellitus, Type 1, Epstein-Barr Virus Infections